Skip to main content

Resources for News Media

The NCI press office is the central news contact for all members of the media. The office can assist you in arranging interviews with NCI researchers and in providing accurate and timely cancer research news and information.

For information about NCI's history and current activities, see NCI Overview and Budget and Appropriations.

Connect with Us

Our office hours are Monday through Friday, 9 a.m. to 5 p.m. ET.

Email: ncipressofficers@mail.nih.gov
Phone: 240-760-6600
Social Media:
@NCIMedia
NCI's YouTube Channel

Address:
Building 31, Room 10A25
31 Center Drive MSC 2580
Bethesda, MD 20892-2580

Recent Interviews from Scientists at NCI

From left to right, Douglas R. Lowy, M.D., Megan Clarke, Ph.D., M.H.S., Steven A. Rosenberg, M.D., Ph.D., Brigitte C. Widemann, M.D., Satish Gopal, M.D., M.P.H., and Worta McCaskill-Stevens, M.D., M.S.

From left to right, Douglas R. Lowy, M.D., Megan Clarke, Ph.D., M.H.S., Steven A. Rosenberg, M.D., Ph.D., Brigitte C. Widemann, M.D., Satish Gopal, M.D., M.P.H., and Worta McCaskill-Stevens, M.D., M.S.

  • Study uncovers clues to rise in uterine cancer death rates

    May 5, 2022 | AP News
    A rare but aggressive kind of uterine cancer appears to be driving an increase in U.S. deaths from the disease, particularly among Black women, researchers reported Thursday.

  • Study: Black, Hispanic Women More Likely To Die From Uterine Cancer

    May 5, 2022 | Newsy
    More aggressive non-endometroid uterine cancer deaths increased by almost 3% per year. Black women face the harshest fatality rates.

  • NCI Leaders Optimistic about Meeting President’s Goal

    April 11, 2022 | Cancer Discovery
    Current NCI Director Norman “Ned” Sharpless, MD, and Douglas Lowy, MD, who will become acting director following Sharpless’s departure from the institute at the end of April, are confident that the cancer community can reach President Joe Biden’s goal to cut deaths from cancer in half within 25 years. They identified several opportunities to improve cancer screening, prevention efforts, and treatment that could contribute to a declining death rate.

  • NCI program to provide molecular characterization of childhood cancers

    March 21, 2022 | Healio
    Dr. Brigitte Widemann talks about the Molecular Characterization Initiative.

  • Global Health and the National Cancer Institute

    January 27, 2022 | That Medic Podcast
    In this episode, we spoke to Dr. Satish Gopal, Director of the Center for Global Health at the National Cancer Institute. We discussed why students should care about global health, his experience as the only certified medical oncologist in Malawi, a country of 18 million, and how he is helping bridge disparities in the global cancer burden.

  • Black Women And The Breast Cancer Disparity

    October 8, 2021 | Newsy
    After years of spreading the same message, two women combined their efforts to help educate and support other Black women before and after diagnosis.

Trending Topics

  • Cancer Cabinet Community Conversations: Doubling Clinical Trials Accrual

    The National Cancer Institute hosted a virtual roundtable titled “Cancer Cabinet Community Conversations: Doubling Clinical Trials Accrual” as part of a series of coordinated Cancer Cabinet Community Conversations on May 4, 2022, as part of the Cancer Moonshot Initiative. This is a recording on YouTube.

  • Uterine Cancer—Patient Version

    Uterine cancers can be of two types: endometrial cancer (common) and uterine sarcoma (rare). Endometrial cancer can often be cured. Uterine sarcoma is often more aggressive and harder to treat. Start here to find information on uterine cancer treatment, causes and prevention, screening, research, and statistics.

  • NCI COVID-19 in Cancer Patients Study (NCCAPS)

    The NCI COVID-19 in Cancer Patients Study, or NCCAPS, is a natural history study of COVID-19 in people with cancer. The knowledge gained from this study will help doctors better manage treatment for people with cancer and COVID-19 in the future.

  • Immunotherapy to Treat Cancer

    Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. This page covers the types of immunotherapy, how it is used against cancer, and what you can expect during treatment.

Multimedia from NCI

Recent News Releases